These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4261530)

  • 1. L-dopa effect in Huntington's chorea.
    Fahn S
    N Engl J Med; 1972 Aug; 287(9):467-8. PubMed ID: 4261530
    [No Abstract]   [Full Text] [Related]  

  • 2. Huntington's chorea--the rigid form (Westphal variant) treated with l-DOPA: a case report.
    Low PA; Allsop JL
    Proc Aust Assoc Neurol; 1973; 10(0):45-6. PubMed ID: 4275960
    [No Abstract]   [Full Text] [Related]  

  • 3. Parkinsonism and Huntington's chorea.
    Yuill GM
    Lancet; 1971 Jan; 1(7688):44. PubMed ID: 4099351
    [No Abstract]   [Full Text] [Related]  

  • 4. A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea.
    Walters AS; McHale D; Sage JI; Hening WA; Bergen M
    Clin Neuropharmacol; 1990 Jun; 13(3):236-40. PubMed ID: 2141544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biogenic amines in the hypothalamus: effect of L-DOPA on human growth hormone levels in patients with Huntington's chorea.
    Podolsky S; Leopold NA
    Prog Brain Res; 1973; 39():225-35. PubMed ID: 4275115
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of L-dopa in the detection of presymptomatic Huntington's chorea.
    Klawans HL; Paulson GW; Ringel SP; Barbeau A
    N Engl J Med; 1972 Jun; 286(25):1332-4. PubMed ID: 4260358
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Rigidity in Huntington's chorea.
    Bird ED; Iversen LL
    Lancet; 1974 Mar; 1(7855):463. PubMed ID: 4131474
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyridoxine reversal of L-dopa effects in Parkinsonism.
    Duvoisin RC; Yahr MD; Coté LD
    Trans Am Neurol Assoc; 1969; 94():81-4. PubMed ID: 5374494
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth hormone abnormalities in Huntington's chorea: effect of L-dopa administration.
    Podolsky S; Leopold NA
    J Clin Endocrinol Metab; 1974 Jul; 39(1):36-9. PubMed ID: 4276011
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long term treatment of a parkinsonism with l-dopa].
    Presthus J
    Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069
    [No Abstract]   [Full Text] [Related]  

  • 11. [Huntington's chorea and Parkinson's disease. Physiopathological antagonism in relation to the blink reflex].
    Esteban A; Gimenez-Roldan S
    Arch Neurobiol (Madr); 1974; 37(4):337-54. PubMed ID: 4279639
    [No Abstract]   [Full Text] [Related]  

  • 12. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haloperidol in dopa-induced choreo-athetosis.
    Postma JU
    Psychiatr Neurol Neurochir; 1972; 75(1):69-71. PubMed ID: 5024898
    [No Abstract]   [Full Text] [Related]  

  • 14. Apomorphine, pimozide, L-Dopa and the probenecid test in Huntington's chorea.
    Lal S; De la Vega C; Garelis E; Sourkes TL
    Psychiatr Neurol Neurochir; 1973; 76(2):113-7. PubMed ID: 4267059
    [No Abstract]   [Full Text] [Related]  

  • 15. Short-term variability in amplitude and motor topography of whole-body involuntary movements in Parkinson's disease dyskinesias and in Huntington's chorea.
    Fenney A; Jog MS; Duval C
    Clin Neurol Neurosurg; 2008 Feb; 110(2):160-7. PubMed ID: 18063471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
    Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
    Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in Parkinson's disease and Huntington's chorea.
    Barbeau A
    Int J Neurol; 1976; 11(1):17-27. PubMed ID: 138661
    [No Abstract]   [Full Text] [Related]  

  • 18. Modification of Parkinsonism--chronic treatment with L-dopa.
    Cotzias GC; Papavasiliou PS; Gellene R
    N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641
    [No Abstract]   [Full Text] [Related]  

  • 19. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment.
    Tolosa ES
    Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypokinesia in Huntington's disease.
    van Vugt JP; van Hilten BJ; Roos RA
    Mov Disord; 1996 Jul; 11(4):384-8. PubMed ID: 8813217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.